Quality of Life in Postmenopausal Women Who Are Receiving Either Exemestane or Anastrozole With or Without Celecoxib for Stage I, Stage II, or Stage IIIA Primary Breast Cancer

NCT00090974 · clinicaltrials.gov ↗
COMPLETED
Status
NETWORK
Sponsor class

Conditions

Interventions

Sponsor

Eastern Cooperative Oncology Group

Collaborators